Filing Details
- Accession Number:
- 0001104659-25-007682
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-01-30 18:39:26
- Reporting Period:
- 2025-01-28
- Accepted Time:
- 2025-01-30 18:39:26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1403708 | Evoke Pharma Inc | EVOK | Pharmaceutical Preparations (2834) | 208447886 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1472322 | Nantahala Capital Management, Llc | 130 Main St. 2Nd Floor New Canaan CT 06840 | No | No | Yes | No | |
| 1775831 | Daniel Mack | 130 Main St. 2Nd Floor New Canaan CT 06840 | No | No | Yes | No | |
| 1775952 | B. Wilmot Harkey | 130 Main St. 2Nd Floor New Canaan CT 06840 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2025-01-28 | 41 | $4.39 | 148,153 | No | 4 | S | Indirect | See footnote |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | See footnote |
Footnotes
- Nantahala Capital Management, LLC ("NCM"), an investment adviser to certain private funds and managed accounts (the "NCM Investors") that hold the Evoke Pharma, Inc. ("Issuer") securities disclosed in this statement, may be deemed a beneficial owner of such securities. Each of Mr. Wilmot B. Harkey and Mr. Daniel Mack may be deemed a beneficial owner of Issuer securities beneficially owned by NCM. Each of NCM, Mr. Harkey and Mr. Mack disclaims beneficial ownership of the Issuer's securities disclosed herein except to the extent of their respective pecuniary interests therein.
Billionaire Hedge Funds
